Skip to main content
Equibles

Invesco Ltd.

Position in REPL — Replimune Group, Inc.

CIK 914208 Atlanta, GA
Back to REPL Full portfolio

Position in REPL

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$8,017,379
+$6,556,805 QoQ
Shares Held
724,244
+279.3% QoQ
Ownership
0.769%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#26
of 199 holders
Holding Since
Jun 2021
21 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in REPL Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Invesco Ltd. holds $14,420,023,301 across 296 Biotechnology names. REPL ranks #61 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 8,043,052 $3,995,225,212
2 REGN
Regeneron Pharmaceuticals, Inc.
 3,940,665 $2,457,162,245
3 ALNY
Alnylam Pharmaceuticals, Inc.
 3,754,318 $1,130,162,341
4 INCY
Incyte Corp
 4,080,461 $462,561,050
5 ARGX
Argenx SE
 443,990 $411,920,598
6 AXSM
Axsome Therapeutics, Inc.
 1,671,684 $409,178,086
7 MRNA
Moderna, Inc.
 5,780,299 $404,794,337
8 LGND
Ligand Pharmaceuticals Inc
 1,201,644 $379,827,645

All Filings in REPL

Export CSV
21 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $8,017,379 724,244
2026-03-31 $1,460,574 190,925
2025-12-31 $5,958,504 613,015
2025-09-30 $646,520 154,301
2025-06-30 $1,108,564 119,329
2025-03-31 $3,142,843 322,343
2024-12-31 $1,065,750 88,006
2024-09-30 $1,983,298 180,958
2024-06-30 $770,382 85,598
2024-03-31 $707,986 86,657
2023-12-31 $187,314 22,220
2023-09-30 $379,704 22,192
2023-06-30 $414,847 17,866
2023-03-31 $345,516 19,565
2022-12-31 $2,562,401 94,206
2022-09-30 $594,502 34,424
2022-06-30 $599,021 34,269
2022-03-31 $524,002 30,860
2021-12-31 $335,334 12,374
2021-09-30 $401,888 13,559
2021-06-30 $4,486,840 116,784